Retavacyl 375

Yeluri Formulations Pvt Ltd.🇵🇭 Food and Drug Administration - Philippines

Approval Id: a25ff0677d138c25
Drug Approval Philippines Name: Retavacyl 375
Product Name: Retavacyl 375
Registration Number: DRP-12930-03
Brand Name: Retavacyl 375
Generic Name: Co-Amoxiclav
Dosage Form: Film-Coated Tablet
Dosage Strength: 375 mg
Manufacturer: Yeluri Formulations Pvt Ltd.
Importer: Medinova Pharmaceutical Inc.
Distributor: Reta Drug
Issuance Date: 24 September 2024
Expiry Date: 03 November 2027
Pharmacologic Category: Antibacterial (Penicillin + Beta-Lactamase Inhibitor)
Classification: Prescription Drug (Rx)

Approved

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

a25ff0677d138c25

Type

Standard